Sign in

CIK 0001400118 · <br>Emerging growth company

Sagimet Biosciences Inc.

Sign in to watch
Ticker
SGMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
205991472
Phone
(650) 561-8600
Business address
950 TOWER LANE, STE 1500, FOSTER CITY, CA, 94404
Former names
3-V Biosciences, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-28 Grauer Andreas Chief Medical Officer Grant or award · Stock Option (Right to Buy) +35,000 35,000
2026-05-28 Rozek Elizabeth Chief Legal & Admin. Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2026-05-28 Happel David President & CEO Grant or award · Stock Option (Right to Buy) +300,000 300,000
2026-04-20 Grauer Andreas Chief Medical Officer Grant or award · Stock Option (Right to Buy) +264,759 264,759
2026-02-19 Rozek Elizabeth Chief Legal & Admin. Officer Grant or award +44,000 234,959
2026-02-19 Rozek Elizabeth Chief Legal & Admin. Officer Grant or award · Stock Option (Right to Buy) +88,000 88,000
2026-02-19 Martins Eduardo Bruno Chief Medical Officer Grant or award +44,000 147,296
2026-02-19 Martins Eduardo Bruno Chief Medical Officer Grant or award · Stock Option (Right to Buy) +88,000 88,000
2026-02-19 Happel David President & CEO Grant or award +128,000 805,621
2026-02-19 Happel David President & CEO Grant or award · Stock Option (Right to Buy) +256,000 256,000
2026-02-19 Chauche Thierry Chief Financial Officer Grant or award +44,000 59,688
2026-02-19 Chauche Thierry Chief Financial Officer Grant or award · Stock Option (Right to Buy) +88,000 88,000
2026-02-10 Happel David President & CEO Sale −12,101 $5.36 $65K 677,621
2026-02-10 Chauche Thierry Chief Financial Officer Sale −1,312 $5.36 $7K 15,688
2026-02-10 Martins Eduardo Bruno Chief Medical Officer Sale −3,640 $5.36 $20K 103,296
2026-02-10 Rozek Elizabeth Chief Legal & Admin. Officer Sale −2,622 $5.36 $14K 190,959
2025-11-20 Kemble George Executive Chairman Sale 10b5-1 −37,688 $7.69 $290K 81,005
2025-11-04 Rozek Elizabeth Chief Legal & Admin. Officer Grant or award +9,855 193,581
2025-11-04 Rozek Elizabeth Chief Legal & Admin. Officer Grant or award · Stock Option (Right to Buy) +13,367 13,367
2025-07-21 Happel David President & CEO Sale −65,478 $9.13 $598K 689,722

Page 2 of 10 · 194 trades